Cardiovascular Care
Innovating personalized care along the patient journeyCardiovascular diseases remain the leading cause of death worldwide and continue to contribute to increasing costs in healthcare systems.1 To improve your personalized cardiovascular care delivery, make precise risk assessments, enhance diagnostic confidence, and make well-informed therapy decisions we are committed to partnering with you and providing holistic state-of-the-art solutions.
Our connected cardiovascular care solutions portfolio empowers you to focus on each individual patient and deliver the precise care they need along the entire patient journey.
Discover our product innovations in cardiac imaging and lab test, learn from customer experiences, and get clinical insights with our webinars and news. Our FAQ section provides answers to the most frequently asked questions.
The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.
The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.
European markets for heart valve devices 2010, Millennium Research Group
Cardiac Devices: Global Data 2018; DRG Data Extract 2016 / 2017 – world figures calculated in staged approach
Prevalence model by SHS AT CVC BD based on: [1] Durko et. al (2018), [2] Nkomo et al. (2006), [3] Population data US and Europe, DGR (2019), and Global Data (2019)
Data for CAD & SHD based on “clarivate 2022”; number of procedures in the year 2022; Data for ARR based on “clarivate 2021”; number of procedures
in the year 2022; Data for HF “Global epidemiology and future trends of HF”, G. Lippi, AME Med J 2020;5:15 ;number of patients in the year 2017